1. Home
  2. TFX vs GKOS Comparison

TFX vs GKOS Comparison

Compare TFX & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFX
  • GKOS
  • Stock Information
  • Founded
  • TFX 1943
  • GKOS 1998
  • Country
  • TFX United States
  • GKOS United States
  • Employees
  • TFX N/A
  • GKOS N/A
  • Industry
  • TFX Medical/Dental Instruments
  • GKOS Medical/Dental Instruments
  • Sector
  • TFX Health Care
  • GKOS Health Care
  • Exchange
  • TFX Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • TFX 5.1B
  • GKOS 5.8B
  • IPO Year
  • TFX N/A
  • GKOS 2015
  • Fundamental
  • Price
  • TFX $117.23
  • GKOS $94.32
  • Analyst Decision
  • TFX Hold
  • GKOS Strong Buy
  • Analyst Count
  • TFX 10
  • GKOS 12
  • Target Price
  • TFX $159.63
  • GKOS $134.67
  • AVG Volume (30 Days)
  • TFX 597.8K
  • GKOS 869.3K
  • Earning Date
  • TFX 07-31-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • TFX 1.16%
  • GKOS N/A
  • EPS Growth
  • TFX N/A
  • GKOS N/A
  • EPS
  • TFX 3.20
  • GKOS N/A
  • Revenue
  • TFX $3,010,144,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • TFX $3.50
  • GKOS $27.88
  • Revenue Next Year
  • TFX $5.33
  • GKOS $27.60
  • P/E Ratio
  • TFX $36.60
  • GKOS N/A
  • Revenue Growth
  • TFX 0.29
  • GKOS 23.92
  • 52 Week Low
  • TFX $108.90
  • GKOS $77.10
  • 52 Week High
  • TFX $249.91
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • TFX 49.74
  • GKOS 37.61
  • Support Level
  • TFX $108.90
  • GKOS $92.42
  • Resistance Level
  • TFX $118.81
  • GKOS $98.21
  • Average True Range (ATR)
  • TFX 2.99
  • GKOS 2.85
  • MACD
  • TFX 0.37
  • GKOS -1.10
  • Stochastic Oscillator
  • TFX 64.82
  • GKOS 13.19

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: